Nuwellis Inc vs Xylem, Inc. — how do they compare? Nuwellis Inc trades at $1.49 (market cap $542.80K), while Xylem, Inc. trades at $123.99 (market cap $28.76B). The key difference: Xylem, Inc. is far larger — about 52984.5× Nuwellis Inc's market cap, and Xylem, Inc. pays a 1.4% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | XYL | |
|---|---|---|
Market Cap | $542.80K | $28.76B |
Sector | Technology | Industrials |
52-Week High | $220.50 | $152.95 |
52-Week Low | $1.42 | $106.34 |
Enterprise Value | -$1.27M | $30.54B |
Dividend Yield | — | 1.4% |
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →